Role of the genetic polymorphisms in the 5′-flanking region for transcriptional regulation of the human CYP2E1 gene

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue SUPPL. 1, 2007, Pages

  Uchimoto, Takayuki ^a   Itoga, Sakae ^a   Nezu, Masahiko ^a   Sunaga, Masahiko ^a   Tomonaga, Takeshi ^a   Nomura, Fumio ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

CYP2E1; HeLa cells; HepG2 Cells; Tandem Repeat Polymorphism; Transcriptional Activity

Indexed keywords

CYTOCHROME P450 2E1; PYRAZINE;

CELL STRAIN HEPG2; CONFERENCE PAPER; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME INDUCTION; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TANDEM REPEAT; TRANSCRIPTION REGULATION;

5' FLANKING REGION; CELL LINE, TUMOR; CYTOCHROME P-450 CYP2E1; ENZYME INDUCTION; HELA CELLS; HUMANS; POLYMORPHISM, GENETIC; TANDEM REPEAT SEQUENCES; TRANSFECTION;

EID: 33846325133     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2006.00284.x     Document Type: Conference Paper

References (32)

1. Aster JC, Robertson ES, Hasserjian RP, Turner JR, Kieff E, Sklar J (1997) Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jk or nuclear localization sequences retain the ability to associate with RBP-Jk and active transcription. J Biol Chem 272:11336-11343.
2. Boddy AV, Ratain MJ (1997) Pharmacogenetics in cancer etiology and chemotherapy. Clin Cancer Res 3:1025-1030.
3. Dorsam G, Goetzl EJ (2002) Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphoietic transcription factor Ikaros. J Biol Chem 277:13488-13493.
4. Fairborther KS, Grove J, de Waziers I, Steimel DT, Day CP, Crespi CL, Daly AK (1998) Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8:543-552.
5. Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C, Broxmeyer HE, Hromas R, Pandolfi PP (2001) Mzf1 controls cell proliferation and tumorigenesis. Genes Dev 15:1625-1630.
6. Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 4:391-407.
7. Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110:559-565.
8. Hong J, Pan J, Dong Z, Ning SM, Yang CS (1987) Regulation of N-nitrosodimethylamine demethylase in rat liver and kidney. Cancer Res 47:5948-5953.
9. Howard LA, Ahluwalia J, Lin SK, Sellers EM, Tyndale RF (2003) CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence. Pharmacogenetics 13:321-328.
10. Hu Y, Hakkola J, Oscarson M, Ingelman-Sundberg M (1999) Structural and functional characterization of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochem Biophys Res Commun 263:286-293.
11. Itoga S, Harada S, Nomura F (2001) Polymorphism of the 5′-flanking region of the CYP2E1 gene: an association study with alcoholism. Alcohol Clin Exp Res 25:11S-15S.
12. Itoga S, Nomura F, Harada S, Tsutsumi M, Takase S, Nakai T (1999) Mutations in the exon and exon-intron junction regions of human cytochrome P-450 2E1 gene and alcoholism. Alcohol Clin Exp Res 23:13S-16S.
13. Itoga S, Nomura F, Makino Y, Tomonaga T, Shimada H, Ochiai T, Iizasa T, Baba M, Fujisawa T, Harada S (2002) Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer. Alcohol Clin Exp Res 26:15S-19S.
14. Japenga AC, Davies S, Price RJ, Lake BG (1993) Effect of treatment with pyrazine and some derivatives on cytochrome P450 and some enzyme activities in rat liver. Xenobiotica 23:169-179.
15. Kim SG, Novak RF (1993) The induction of cytochrome P4502E1 by nitrogen- and sulfur-containing heterocycles: expression and molecular regulation. Toxicol Appl Pharmacol 120:257-265.
16. Lieber CS, DeCarli LM (1970) Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem 245:2505-2512.
17. Lieber CS, Garro A, Leo MA, Mak KM, Worner T (1986) Alcohol and cancer. Hepatology 6:1005-1019.
18. Lindros KO (1995) Alcoholic liver disease: pathobiological aspects. J Hepatol 23:7-15.
19. Marchand LL, Donlon T, Seifried A, Wilkens RL (2002) Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomark Prev 11:1019-1024.
20. Margalit Y, Yarus S, Shapira E, Gruenbaum Y, Fainsod A (1993) Isolation and characterization of target sequences of the chicken CdxA homebox gene. Nucleic Acids Res 21:4915-4922.
21. McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorozoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 152:276-281.
22. Nomura F, Itoga S, Uchimoto T, Tomonaga T, Nezu M, Shimada H, Ochiai T (2003) Transcriptional activity of the tandem repeat polymorphism in the 5′-flanking region of the human CYP2E1 gene. Alcohol Clin Exp Res 27:42S-46S.
23. Nomura F, Pikkarainen PH, Jauhonen P, Arai M, Gordon ER, Baraona E, Lieber CS (1983) Effect of ethanol administration on the metabolism of ethanol in baboons. J Pharmacol Exp Ther 227:78-83.
24. Oneta CM, Lieber CS, Li JJ, Ruttimann S, Schmid B, Lattmann J, Rosman AS, Seitz HK (2002) Dynamics of cytochrome P4502E1 activity in man. Induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47-52.
25. Plee-Gautier E, Foresto F, Ferrara R, Bodenez P, Manno SM, Berthou F, Lucas D (2001) Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics. Alcohol Clin Exp Res 25:800-804.
26. Powell H, Kitteringham NR, Pirmohamed M, Smith DA, Park BK (1998) Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 8:411-421.
27. Raucy LJ, Lasker J, Ozaki K, Zoleta V (2004) Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by Clofibrate in primary cultures of human hepatocytes. Toxicol Sci 79:233-241.
28. Rodriguez-Antona C, Donato TM, Boobis A, Edwards JR, Watts SP, Castell VJ, Gomez-Lechon JM (2002) Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32:505-520.
29. Suganuma H, Inakuma T, Kikuchi Y (2002) Amelioratory effect of barley tea drinking on blood fluidity. J Nutr Sci Vitaminol (Tokyo) 48:165-168.
30. Ueshima Y, Tsutsumi M, Takase S, Matsuda Y, Kawahara H (1996) Acetaminophen metabolism in patients with different P4502E1 genotypes. Alcohol Clin Exp Res 20:25A-28A.
31. Watanabe J, Hayashi S, Kawajiri K (1994) Different regulation and expression of the human CYP2E1 gene due to the Rsa1 polymorphism in the 5′-flanking region. J Biochem 116:321-326.
32. Zwedler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN (1996) Gfi-1 encodes a nuclear finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 16:4024-4034.